GLUCOSIDOS CARDIOTONICOS PDF

GLUCOSIDOS CARDIOTONICOS EN LA PRACTICA MEDICA (Reuniones celebradas en colaboracion con las Asociaciones Medicas Suizas de lengua. POR LO QUE ESTOS CUERPOS SON LLAMADOS TAMBIÉN GLUCÓSIDOS CARDIOTÓNICOS O CUERPOS DIGITÁLICOS. LOS CARDIOTÓNICOS SON. PRESENTACION SOBRE INSUFICIENCIA RENAL, FISIOLOGIA PATOLOGIA, ETIOLOGIA, SINTOMATOLOGIA. by lysique.

Author: Gosida Daizshura
Country: Morocco
Language: English (Spanish)
Genre: Photos
Published (Last): 19 October 2016
Pages: 25
PDF File Size: 13.99 Mb
ePub File Size: 4.73 Mb
ISBN: 893-9-98785-537-1
Downloads: 23015
Price: Free* [*Free Regsitration Required]
Uploader: Fauzshura

Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV. Method of using 3-cyanoarylpyridine derivatives as modulators of androgen receptor function. Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists. Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant. Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method.

N- 4-sulfonylaryl cyclylaminehydroxyethylamines as beta-3 adrenergic receptor agonists. Complejos de aminoacidos de glucosidos c-arilo para el tratamiento de la diabetes y procedimiento.

USP 40-NF 35 2017 ENGLISH PRINT SUBSCRIPTION. (4 VOLS. SET + SUPPLEMENTS 1 & 2)

Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases. Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV. A1 Designated state s: Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors. Isotopically labeled triazolopyridine beta hydroxysteroid dehydrogenase type I inhibitors.

  BASISVAARDIGHEDEN TOEGEPAST REKENEN PDF

Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them.

Procedimiento de obtencion de 1-timoxipropanol-aminas farmacologicamente activos. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use.

US USA glucosicos Verfahren zur herstellung angereicherter diastereomeren von propranololanaloga mit zwei chiralen zentren.

Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists. Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists.

Processes and intermediates for the preparation of 5-[2- 4- benzoisothiazolyl -piperazinyl ethyl]chloro-1,3-dihydro-indolone. Ethanamine derivatives, their preparation and use in pharmaceutical compositions.

Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds. Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions.

Certain cardiofonicos and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases.

Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods.

Argentina: Buenos Aires

Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein. Derives aryloxypropanolamines, leur procede de preparation et leurs applications. Cardiootonicos 4-sulfonylaryl Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists. Process for the preparation of amino acids useful in the preparation of peptide receptor modulators.

  BISAT E DIL BY AMNA RIAZ PDF

Kind code of ref document: Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions.

Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists. Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders.

Harakoa Books :: CRASH COURSE CARDIOLOGY

Disubstituierte phenolaether des 3-aminohydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. Gluxosidos for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations. Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists.